X

Vous n'êtes pas connecté

Maroc Maroc - THECEKODOK.COM - A La Une - 02/10/2024 21:52

Another Diabetes Patient Successfully Treated Using Stem Cells

Is diabetes going to be a disease that can finally be treated? This is because another type-1 diabetic patient has been successfully restored using stem cell treatment in China. After receiving a bone marrow transplant procedure, a 25-year-old woman who had diabetes for 11 years no longer needed insulin injections for a year.The treatment was developed by scientists from Tianjin First Central Hospital, Peking University, Changping Laboratory and Hangzhou Reprogenix Bioscience. They take the patient's adipose tissue which is then transformed into stem cells. It is then transformed into islet cells before being transplanted into the patient's abdominal muscles.Islet cells are responsible for producing insulin in the human body. The need for daily insulin injections begins to decrease after two weeks before no longer being needed after 75 days. The patient's body produced its own insulin again and he was successfully treated.What makes the success of this Chinese scientist unique is that the islet cells were transplanted into the abdominal muscles instead of the patient's liver as was done on the first human recovered from diabetes three years ago in the United States. Transplantation to the abdominal muscles is easier than to the liver because it does not require complicated surgery. The study was published in the journal Cell.

Articles similaires

Sorry! Image not available at this time

Needle-free diabetes management could be on the horizon, study suggests

wn.com - 20/Mar 11:37

Oral insulin could one day replace injections for people...

Sorry! Image not available at this time

Needle-free diabetes management could be on the horizon, study suggests

wn.com - 20/Mar 11:37

Oral insulin could one day replace injections for people...

EVA1A regulates fatty acid transporter CD36 in fatty liver disease

news.medical.net - 10/Mar 00:21

Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) is characterized by excessive accumulation of lipids in hepatocytes and is closely...

EVA1A regulates fatty acid transporter CD36 in fatty liver disease

news.medical.net - 10/Mar 00:21

Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) is characterized by excessive accumulation of lipids in hepatocytes and is closely...

Sorry! Image not available at this time

Local stem cell programme saves lives, costs – Public blood donations needed for growth

economist.com.na - 20/Mar 10:29

The groundbreaking stem cell transplant programme is officially expanding, but experts warn its future growth depends entirely on one factor: the...

Sorry! Image not available at this time

Lab-grown food pipe offers new hope for young patients

bbc - 20/Mar 10:41

UK scientists have grown fully functioning food pipes and successfully transplanted them into mini pigs, paving the way for human trials.

Sorry! Image not available at this time

Lab-grown food pipe offers new hope for young patients

wn.com - 20/Mar 11:00

UK scientists have grown fully functioning food pipes and successfully transplanted them into mini pigs, paving the way for human trials. ......

Sorry! Image not available at this time

Clinical trial eyed for spinal cord treatment with iPS cells

wn.com - 18/Mar 22:04

A pharmaceutical startup plans to begin a clinical trial in 2027 on a treatment for spinal cord injuries that uses nerve cells engineered from induced...

Sorry! Image not available at this time

Clinical trial eyed for spinal cord treatment with iPS cells

wn.com - 18/Mar 22:04

A pharmaceutical startup plans to begin a clinical trial in 2027 on a treatment for spinal cord injuries that uses nerve cells engineered from induced...

Sorry! Image not available at this time

NeuroScientific readies stem cell supply boost for bowel disease trials

smh.com.au - 17/Mar 00:33

NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of...